Welcome to our dedicated page for National Vision SEC filings (Ticker: EYE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From low-cost eye exams at America’s Best to Vision Centers hosted inside Walmart, National Vision’s growth story lives inside its SEC disclosures. We bring every National Vision SEC filing explained simply, turning hundreds of optical-retail pages into clear takeaways you can act on.
Need the numbers fast? Our AI-powered summaries break down —
- National Vision quarterly earnings report 10-Q filing: store-level comps, lens lab capacity and managed-care mix.
- National Vision annual report 10-K simplified: segment margins, lease obligations and clinic expansion risks.
- National Vision 8-K material events explained: partner renewals, leadership changes and unexpected disruptions.
- National Vision insider trading Form 4 transactions with real-time alerts, plus a complete log of National Vision executive stock transactions Form 4.
- National Vision proxy statement executive compensation insights, including optometrist incentive structures.
Every document hits our site the moment it posts to EDGAR, so National Vision Form 4 insider transactions real-time alerts arrive before the market digests them. Interactive charts and plain-English notes support understanding National Vision SEC documents with AI, letting you compare eyewear unit economics across quarters or perform National Vision earnings report filing analysis without sifting through footnotes.
Whether you’re monitoring optical retail trends, verifying compliance metrics, or watching National Vision insider trading Form 4 transactions, our platform gives you the clarity and speed needed to make informed decisions.
National Vision Holdings (EYE) reported Q3 results. Total net revenue was $487.3 million versus $451.5 million a year ago, driven by higher product sales and services. Income from operations was $9.6 million, compared to a loss last year, and net income was $3.4 million, or $0.04 per diluted share, versus a loss of $0.11. For the first nine months, revenue reached $1.48 billion with net income of $26.3 million, or $0.33 per diluted share.
Operating cash flow was $133.1 million for the nine months, supporting capital expenditures and debt reduction. The company fully repaid its 2.50% convertible senior notes due May 2025 and ended the quarter with Term Loan A of $244.3 million and no revolver borrowings. Cash and cash equivalents were $56.0 million. The company operated 1,242 stores as of September 27, 2025. Subsequent to quarter‑end, an investee agreed to be acquired, and EYE expects repayment in cash of its preferred equity and note balances with no gain or loss.
National Vision Holdings, Inc. (EYE) furnished a Form 8-K announcing it issued a press release with financial results for the quarter ended September 27, 2025. The press release is included as Exhibit 99.1 pursuant to Item 2.02 (Results of Operations and Financial Condition).
The information is being furnished to the SEC and is not deemed filed under Section 18 of the Exchange Act, nor incorporated by reference unless specifically stated.
National Vision Holdings, Inc. (EYE) insider reporting: The filing discloses that Priti V. Patel, a General Manager and officer, had 1,502 restricted stock units vest on
The Form 4 was signed by an attorney-in-fact on
FAHS L Reade, Executive Chairman and Director of National Vision Holdings, Inc. (EYE), reported two open-market sales of company common stock on 09/15/2025 and 09/16/2025 executed under a Rule 10b5-1 trading plan established May 28, 2025. The filing shows a sale of 2,002 shares on 09/15/2025 at a weighted average price of $23.81 and a sale of 10,598 shares on 09/16/2025 at a weighted average price of $23.93. After those transactions the reporting person directly beneficially owned 532,195 shares. The filing also discloses 363,430 shares indirectly held by a trust. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
National Vision Holdings insider transactions disclosed on a Form 144 show proposed and recent sales of common stock by an insider. The filing lists a proposed sale of 10,598 shares through Fidelity Brokerage, with an aggregate market value of $253,629.05, and an approximate sale date of 09/16/2025 on NASDAQ. The securities were acquired via a stock option exercise on 08/16/2021 and paid for in cash. The filing also reports two sales by Leonard R. Fahs on 08/28/2025 (137,400 shares, $3,343,335.27) and 09/15/2025 (2,002 shares, $47,670.10).
National Vision Holdings (EYE): Chief Technology Officer David G. Cutler received 25,997 restricted stock units (RSUs) on 09/08/2025. Each RSU converts one-for-one into common stock, and the full grant equals 25,997 shares outstanding following the award. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant date, so one-third vests each year. The reported position is held directly and the RSUs were granted at a $0 per-share exercise price (standard for restricted stock units). This is a routine equity compensation award to an executive designed to align compensation with shareholder interests.
National Vision Holdings insider award: Ana Moeddel, SVP and Chief Merchandising & MC Officer, was granted 34,185 restricted stock units (RSUs) on 09/02/2025. Each RSU converts one-for-one into common stock of the company. The award is reported as direct ownership of 34,185 shares following the grant and carries a reported price of $0. One-third of the RSUs will vest on each anniversary of the grant date, beginning September 2, 2025. The Form 4 was signed by an attorney-in-fact on 09/03/2025.
Insider sales by Executive Chairman Fahs L. Reade were disclosed on Form 4 for National Vision Holdings, Inc. (EYE). The filing reports two separate open-market sales executed on 08/28/2025 under a Rule 10b5-1 trading plan established May 28, 2025, totaling 137,400 shares sold at weighted-average prices of $23.85 and $24.76. After the transactions the reporting person is shown with directly beneficial ownership of 617,525 shares on one line and 544,795 shares on another line, and indirect beneficial ownership of 363,430 shares held by a trust. The Form 4 was signed by an attorney-in-fact.
FAQ
What is the current stock price of National Vision (EYE)?
What is the market cap of National Vision (EYE)?
